CD274 and urinary bladder cancer: Pfannstiel et al. [42] conducted a study showing that high levels of TIL in bladder cancer were associated with increased expression of immune checkpoints such as PD-1 and PD-L1, tumor antigens, and mutational load, suggesting that bladder cancer patients with high infiltrating lymphocytes would benefit more from ICIs.